iDayo Selects LGND as Low Risk Investment

Call Now
800-993-0005

Conference Calls

(^DJI) 0

0S&P 500 (^GSPC) 1318.86

2.23NASDAQ Composite (^IXIC) 2850.12

0Russell 2000 (^RUT) 765.17

0

Request Information

Low Risk Investments

12 Year Track Record

iDayo In the News

iDayo In Forbes

iDayo™ Stock Selector: LGND - Ligand Pharmaceuticals Inc

iDayo™ 09/05/06: Ligand Pharmaceuticals Inc (LGND) - 09/05/06

For the 16 week investment period starting 09/05/06 , the iDayo™ Stock Selector rated Ligand Pharmaceuticals Inc (LGND) as "Extreme Accumulation" and selected LGND as a buy for the investment period, identified as iDayo™ 09/05/06.

Company Profile for "Ligand Pharmaceuticals Inc (LGND)": Ligand Pharmaceuticals Incorporated engages in the discovery, development, and marketing of drugs.

Google Finance History for LGND

iDayo™ 09/15/03: Ligand Pharmaceuticals Inc (LGND) - 09/15/03

For the 16 week investment period starting 09/15/03 , the iDayo™ Stock Selector rated Ligand Pharmaceuticals Inc (LGND) as "Extreme Accumulation" and selected LGND as a buy for the investment period, identified as iDayo™ 09/15/03.

Company Profile for "Ligand Pharmaceuticals Inc (LGND)": Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, mens and womens health or hormone-related health issues.

Google Finance History for LGND

iDayo, Inc. (including its marketing professionals and staff), is not a registered Investment Advisor or Broker/Dealer, and does not provide investment advice or recommendations. Subscribers to iDayo™ are advised that the information, opinions, and analysis included in our web sites, on our free Educational Conference Calls, or in any other communication are based in good faith on sources believed to be reliable, but no representation or warranty, expressed or implied, is made as to their accuracy, completeness, or correctness.

Past performance is not necessarily indicative of the future performance of stocks posted. None of these postings, the iDayo™ system rating, nor any other information provided on our web sites, on our free Educational Conference Calls, or in any other communication constitutes a recommendation to buy or sell stocks or any other investment. Investing involves the risk of loss and Subscribers are urged to consult with their own independent financial advisors with respect to any investment.